Association study of energy homeostasis genes and antipsychotic-induced weight gain in patients with schizophrenia

Pharmacopsychiatry

Volumn 44, Issue 1, 2011, Pages 15-20

  Jassim, G ^a,b   Ferno J ^a,b   Theisen, F M ^c   Haberhausen, M ^c   Christoforou, A ^a,b   Havik B ^a,b   Gebhardt, S ^c   Remschmidt, H ^c   Mehler Wex, C ^e   Hebebrand, J ^d   Lehellard, S ^a,b   Steen, V M ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ADIPONECTIN; CLOZAPINE; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 3; NEUROLEPTIC AGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALPHA CHAIN; ARTICLE; BETA CHAIN; BODY MASS; BODY WEIGHT; CHILD; ENERGY METABOLISM; FEMALE; FTO GENE; GENE; GENETIC ASSOCIATION; GENOTYPE; GERMANY; HOMEOSTASIS; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PRKAA1 GENE; PRKAA2 GENE; PRKAB1 GENE; PRKAG1 GENE; PRKAG2 GENE; PRKAG3 GENE; SCHIZOPHRENIA; SCHOOL CHILD; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT GAIN;

ADIPONECTIN; ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CHILD; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENOTYPE; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; WEIGHT GAIN; YOUNG ADULT;

EID: 78951469329     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0030-1263174     Document Type: Article

References (44)

1. Allison DB, Casey DE. Antipsychotic-induced weight gain: a review of the literature. J Clin Psychiatry 2001 62 22-31
2. Andersson U, Filipsson K, Abbott CR, et al. AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem 2004 279 12005-12008
3. Arranz MJ, de Leon J. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. Mol Psychiatry 2007 12 707-747
4. Bai YM, Chen JY, Yang WS, et al. Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia. J Clin Psychiatry 2007 68 1834-1839
5. Bai YM, Chen TT, Yang WS, et al. Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study. Schizophr Res 2009 111 1-8
6. Bai YM, Lin CC, Chen JY, et al. Association of initial antipsychotic response to clozapine and long-term weight gain. Am J Psychiatry 2006 163 1276-1279
7. Basile VS, Masellis M, De Luca V, et al. 759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain. Lancet 2002 360 1790-1791
8. Birkenaes AB, Birkeland KI, Friis S, et al. Hormonal markers of metabolic dysregulation in patients with severe mental disorders after olanzapine treatment under real-life conditions. J Clin Psychopharmacol 2009 29 109-116
9. Carling D. The AMP-activated protein kinase cascade - a unifying system for energy control. Trends Biochem Sci 2004 29 18-24 (Pubitemid 38068476)
10. Cheung PC, Salt IP, Davies SP, et al. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem J 2000 346 Pt 3 659-669
11. Correll CU, Malhotra AK. Pharmacogenetics of antipsychotic-induced weight gain. Psychopharmacology (Berl) 2004 174 477-489
12. Ellingrod VL, Perry PJ, Ringold JC, et al. Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine. Am J Med Genet B Neuropsychiatr Genet 2005 134B 76-78
13. Ferno J, Raeder MB, Vik-Mo AO, et al. Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action? Pharmacogenomics J 2005 5 298-304
14. Ferno J, Skrede S, Vik-Mo AO, et al. Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs. BMC Neurosci 2006 7 69
15. Ferno J, Vik-Mo AO, Jassim G, et al. Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver. Psychopharmacology (Berl) 2009 203 73-84
16. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007 316 889-894
17. Gregoor JG, van der Weide J, Mulder H, et al. Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication. J Clin Psychopharmacol 2009 29 21-25
18. Hardie DG. AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol 2007 47 185-210
19. Heid IM, Henneman P, Hicks A, et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4 659 European individuals. Atherosclerosis 2010 208 412-420
20. Hivert MF, Manning AK, McAteer JB, et al. Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes 2008 57 3353-3359
21. Juutinen J, Hakko H, Meyer-Rochow VB, et al. Body mass index (BMI) of drug-naive psychotic adolescents based on a population of adolescent psychiatric inpatients. Eur Psychiatry 2008 23 521-526
22. Kadowaki T, Yamauchi T, Kubota N, et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006 116 1784-1792
23. Kahn BB, Alquier T, Carling D, et al. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005 1 15-25
24. Kang SG, Lee HJ, Park YM, et al. Possible association between the 2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain. Prog Neuropsychopharmacol Biol Psychiatry 2008 32 160-163
25. Kim SF, Huang AS, Snowman AM, et al. Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase. PNAS 2007 104 3456-3459
26. Le Hellard S, Theisen FM, Haberhausen M, et al. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects? Mol Psychiatry 2009 14 308-317
27. Leucht S, Corves C, Arbter D, et al. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009 373 31-41
28. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005 353 1209-1223
29. Lopez M, Lage R, Saha AK, et al. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab 2008 7 389-399
30. Melkersson K, Dahl ML. Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications. Drugs 2004 64 701-723
31. Miller DD, Ellingrod VL, Holman TL, et al. Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism. Am J Med Genet B Neuropsychiatr Genet 2005 133B 97-100
32. Minokoshi Y, Alquier T, Furukawa N, et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004 428 569-574
33. Opgen-Rhein C, Brandl EJ, Muller DJ, et al. Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample. Pharmacogenomics 2010 11 773-780
34. Raeder MB, Ferno J, Vik-Mo AO, et al. SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects? Mol Cell Biochem 2006 289 167-173
35. Reynolds GP, Zhang Z, Zhang X. Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain. Am J Psychiatry 2003 160 677-679
36. Reynolds GP, Zhang ZJ, Zhang XB. Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet 2002 359 2086-2087
37. Templeman LA, Reynolds GP, Arranz B, et al. Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis. Pharmacogenet Genomics 2005 15 195-200
38. Thakore JH, Mann JN, Vlahos I, et al. Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int J Obes Relat Metab Disord 2002 26 137-141
39. Theisen FM, Hinney A, Bromel T, et al. Lack of association between the 759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals. Psychiatr Genet 2004 14 139-142
40. Tiwari AK, Zai CC, Meltzer HY, et al. Association study of polymorphisms in Insulin Induced Gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients. Hum Psychopharmacol 2010 25 253-259
41. Verma SK, Subramaniam M, Liew A, et al. Metabolic risk factors in drug-naive patients with first-episode psychosis. J Clin Psychiatry 2009 70 997-1000
42. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002 8 1288-1295
43. Zhang XY, Tan YL, Zhou DF, et al. Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population. J Clin Psychopharmacol 2007 27 246-251
44. Zhang ZJ, Yao ZJ, Mou XD, et al. Association of -2548G/A functional polymorphism in the promoter region of leptin gene with antipsychotic agent-induced weight gain. Zhonghua Yi Xue Za Zhi 2003 83 2119-2123